PT - JOURNAL ARTICLE AU - Shirley Crankson AU - Subhash Pokhrel AU - Nana Kwame Anokye TI - Determinants of COVID-19 outcomes: A systematic review AID - 10.1101/2021.03.21.21254068 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.21.21254068 4099 - http://medrxiv.org/content/early/2021/03/23/2021.03.21.21254068.short 4100 - http://medrxiv.org/content/early/2021/03/23/2021.03.21.21254068.full AB - Background The current pandemic, COVID-19, caused by a novel coronavirus SARS-CoV-2, has claimed over a million lives worldwide in a year, warranting the need for more research into the wider determinants of COVID-19 outcomes to support evidence-based policies.Objective This study aimed to investigate what factors determined the mortality and length of hospitalisation in individuals with COVID-19.Data Source This is a systematic review with data from four electronic databases: Scopus, Google Scholar, CINAHL and Web of Science.Eligibility Criteria Studies were included in this review if they explored determinants of COVID-19 mortality or length of hospitalisation, were written in the English Language, and had available full-text.Study appraisal and data synthesis The authors assessed the quality of the included studies with the Newcastle□Ottawa Scale and the Agency for Healthcare Research and Quality checklist, depending on their study design. Risk of bias in the included studies was assessed with risk of bias assessment tool for non-randomised studies. A narrative synthesis of the evidence was carried out. The review methods were informed by the Joana Briggs Institute guideline for systematic reviews.Results The review included 22 studies from nine countries, with participants totalling 239,830. The included studies’ quality was moderate to high. The identified determinants were categorised into demographic, biological, socioeconomic and lifestyle risk factors, based on the Dahlgren and Whitehead determinant of health model. Increasing age (ORs 1.04-20.6, 95%CIs 1.01-22.68) was the common demographic determinant of COVID-19 mortality while living with diabetes (ORs 0.50-3.2, 95%CIs −0.2-0.74) was one of the most common biological determinants of COVID-19 length of hospitalisation.Review limitation Meta-analysis was not conducted because of included studies’ heterogeneity.Conclusion COVID-19 outcomes are predicted by multiple determinants, with increasing age and living with diabetes being the most common risk factors. Population-level policies that prioritise interventions for the elderly population and the people living with diabetes may help mitigate the outbreak’s impact.PROSPERO registration number CRD42021237063.Strength and limitations of this reviewThis is the first systematic review synthesising the evidence on determinants of COVID-19 LOS outcome.It is also the first review to provide a comprehensive investigation of contextual determinants of COVID-19 outcomes, based on the determinants of health model; thus, presenting with crucial gaps in the literature on the determinants of COVID-19 outcomes that require urgent attention.The review was restricted in conducting meta-analysis due to included studies’ heterogeneity.The review focused on only papers published in the English Language; hence, other relevant papers written on other languages could have been omitted.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/PROSPERO Funding StatementThe authors did not receive any funding for this study from any funding agency in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Brunel University ethics committeeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are either included in this article or added to the supplementary information.